Evidence map›Paper›PMID 38346277›Full record

ReviewAnnual review of biomedical engineering2024

Histotripsy: A Method for Mechanical Tissue Ablation with Ultrasound.

Zhen Xu, Tatiana D Khokhlova, Clifford S Cho, Vera A Khokhlova

Abstract readReview
In one paragraph

Review in Annual review of biomedical engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Injectable radiopaque targets for cone-beam CT guided histotripsy.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026
    Article
  3. Review
  4. Article
  5. [Interventional therapeutic strategies for metastatic liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  6. Histotripsy for Liver Tumors: Breakthrough or Hype?Annals of surgical oncology · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhen XuDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA; email: zhenx@umich.edu.
Tatiana D KhokhlovaApplied Physics Laboratory, University of Washington, Seattle, Washington, USA.
Clifford S ChoDepartment of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Vera A KhokhlovaDepartment of Acoustics, Lomonosov Moscow State University, Moscow, Russia.

Funding

Image-Guided Non-Invasive Ultrasonic Thrombolysis Using HistotripsyR01EB008998 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XU, ZHEN · 2008 to 2017
$4.5M
Integrated Dual-frequency Ultrasound Catheter for Accelerated Sonothrombolysis (iDUCAS)R01HL141967 · NHLBI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Xiaoning Jiang, Zhen Xu · 2018 to 2026
$4.1M
Histotripsy for Urinary Stone ComminutionR01DK091267 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HALL, TIMOTHY L · 2011 to 2020
$3.4M
Transrectal Histotripsy for Focal Ablation of Prostate CancerR01CA258581 · NCI · UNIVERSITY OF WASHINGTON · PI SCHADE, GEORGE R · 2022 to 2025
$3.1M
Novel, Noninvasive, Rapid Tumor Ablation Technology using HistotripsyR01CA211217 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XU, ZHEN · 2018 to 2022
$2.7M
Novel Ultrasonic Technique for the Treatment of Hemorrhagic StrokeR01NS108042 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PANDEY, ADITYA S · 2018 to 2022
$2.6M
Transcranial Magnetic Resonance guided Histotripsy (tcMRgHt)R01EB028309 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XU, ZHEN · 2019 to 2022
$2.4M
Ultrasound-guided Ultra-steerable Histotripsy Array System for Non-invasive treatment of Soft Tissue SarcomaR01EB034399 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Zhen Xu · 2023 to 2026
$2.2M
Acoustic Cavitation Emission (ACE) Feedback Methods for Monitoring Histotripsy-Induced Tissue Fractionation In SituR01EB032772 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUKOVICH, JONATHAN ROBERT · 2022 to 2025
$2.0M
Transcranial MRI- and Ultrasound- guided histotripsy (tcMR-USgHt) systemR01EB037129 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Zhen Xu · 2025 to 2026
$1.2M
Novel Ultrasonic Technology to Treat Hemorrhagic StrokeR21NS093121 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XU, ZHEN · 2015 to 2016
$426k
Non-invasive Transcranial Histotripsy Treatment in a Murine Primary Malignant Brain Tumor ModelR21CA260684 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PANDEY, ADITYA S, XU, ZHEN · 2021 to 2021
$384k
BLRD VA I01 BX001619NCI NIH HHS R01 CA211217NCI NIH HHS R01 CA258581NCI NIH HHS R21 CA260684NHLBI NIH HHS R01 HL141967NIBIB NIH HHS R01 EB008998NIBIB NIH HHS R01 EB028309NIBIB NIH HHS R01 EB032772NIBIB NIH HHS R01 EB034399NIBIB NIH HHS R01 EB037129NIDDK NIH HHS R01 DK091267NINDS NIH HHS R01 NS108042NINDS NIH HHS R21 NS093121
6 · The paper itself

Abstract

Histotripsy is a relatively new therapeutic ultrasound technology to mechanically liquefy tissue into subcellular debris using high-amplitude focused ultrasound pulses. In contrast to conventional high-intensity focused ultrasound thermal therapy, histotripsy has specific clinical advantages: the capacity for real-time monitoring using ultrasound imaging, diminished heat sink effects resulting in lesions with sharp margins, effective removal of the treated tissue, a tissue-selective feature to preserve crucial structures, and immunostimulation. The technology is being evaluated in small and large animal models for treating cancer, thrombosis, hematomas, abscesses, and biofilms; enhancing tumor-specific immune response; and neurological applications. Histotripsy has been recently approved by the US Food and Drug Administration to treat liver tumors, with clinical trials undertaken for benign prostatic hyperplasia and renal tumors. This review outlines the physical principles of various types of histotripsy; presents major parameters of the technology and corresponding hardware and software, imaging methods, and bioeffects; and discusses the most promising preclinical and clinical applications.

Indexed as

High-Intensity Focused Ultrasound AblationAnimalsEquipment DesignHumansLiver NeoplasmsMaleNeoplasmsboilingcavitationfocused ultrasound surgeryHIFUhigh-intensity focused ultrasoundhistotripsymechanical bioeffectsnonlinear waves

Identifiers

PMID38346277
PMCPMC11837764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.